DrugPatentWatch Database Preview
Delavirdine mesylate - Generic Drug Details
» See Plans and Pricing
What are the generic drug sources for delavirdine mesylate and what is the scope of freedom to operate?
Delavirdine mesylate
is the generic ingredient in one branded drug marketed by Viiv Hlthcare and is included in one NDA. Additional information is available in the individual branded drug profile pages.Summary for delavirdine mesylate
| US Patents: | 0 |
| Tradenames: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Bulk Api Vendors: | 49 |
| Clinical Trials: | 18 |
| Patent Applications: | 3,726 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | delavirdine mesylate at DailyMed |
Recent Clinical Trials for delavirdine mesylate
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Agouron Pharmaceuticals | N/A |
| National Institute of Allergy and Infectious Diseases (NIAID) | Phase 2 |
| Bristol-Myers Squibb | Phase 2 |
Medical Subject Heading (MeSH) Categories for delavirdine mesylate
US Patents and Regulatory Information for delavirdine mesylate
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Viiv Hlthcare | RESCRIPTOR | delavirdine mesylate | TABLET;ORAL | 020705-001 | Apr 4, 1997 | DISCN | Yes | No | Start Trial | Start Trial | Start Trial | ||||
| Viiv Hlthcare | RESCRIPTOR | delavirdine mesylate | TABLET;ORAL | 020705-002 | Jul 14, 1999 | DISCN | Yes | No | Start Trial | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for delavirdine mesylate
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Viiv Hlthcare | RESCRIPTOR | delavirdine mesylate | TABLET;ORAL | 020705-001 | Apr 4, 1997 | Start Trial | Start Trial |
| Viiv Hlthcare | RESCRIPTOR | delavirdine mesylate | TABLET;ORAL | 020705-001 | Apr 4, 1997 | Start Trial | Start Trial |
| Viiv Hlthcare | RESCRIPTOR | delavirdine mesylate | TABLET;ORAL | 020705-002 | Jul 14, 1999 | Start Trial | Start Trial |
| Viiv Hlthcare | RESCRIPTOR | delavirdine mesylate | TABLET;ORAL | 020705-002 | Jul 14, 1999 | Start Trial | Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
